Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lamia, Hassani"'
Autor:
Moïse Houssen, Philippe-Henri Secretan, Loup Nobilet, Kilian Jossot, Laura Guichard, Cédric Mwamba, David Ngy, Lamia Hassani, Audrey Solgadi, Marie Antignac, Bernard Do, Helga Junot, Hassane Sadou Yayé
Publikováno v:
Pharmaceutics, Vol 16, Iss 8, p 977 (2024)
Doravarine (DOR) is an antiviral drug with a marketed authorization for the management of occupational blood and body fluid exposure. The currently existing packaging, consisting of multiple unit bottles comprising 30 tablets, is not fully appropriat
Externí odkaz:
https://doaj.org/article/f9eb9dc8120d4505b41e25d28cecd492
Autor:
Lucia Parlati, Mehdi Sakka, Aurelia Retbi, Samir Bouam, Lamia Hassani, Jean-François Meritet, Pierre Rufat, Dominique Bonnefont-Rousselot, Rui Batista, Benoit Terris, Agnès Bellanger, Dominique Thabut, Aurore Vozy, Jean-Philippe Spano, Romain Coriat, François Goldwasser, Selim Aractingi, Philippe Sogni, Stanislas Pol, Vincent Mallet, Jérôme Alexandre, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Sixtine De Percin, Nora Kramkimel, Olivier Huillard, Jeanne Chapron, Benedicte Deau-Fischer, Marie-Laure Brandely-Piat, Diane Damotte, Audrey Lupo, Marco Alifano, Marion Corouge, Clémence Hollande, Hélène Fontaine, Lorianne Lair Mehiri, Anaïs Vallet Pichard, Patrick Tilleul
Publikováno v:
JHEP Reports, Vol 5, Iss 12, Pp 100880- (2023)
Background & Aims: There is concern about the burden of liver injury in patients with cancer exposed to immune checkpoints inhibitors (ICIs). Methods: In a retrospective cohort study, we evaluated the likelihood of grade 3/4 liver injury, of grade 3/
Externí odkaz:
https://doaj.org/article/788878b251bf4c95a2f7143042e64143
Autor:
Maria Gloria Tarantini, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Agnès Bellanger, Julien Mayaux, Patrick Tilleul, Fadwa El Kouari, Hassane Sadou Yayé
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 550 (2022)
Background: The SARS-CoV-2 pandemic has resulted in a dramatic rise of the demand for medical devices and drugs. In this context, an important shortage of programmable syringe pumps, used to administrate different drugs in intensive care units, was s
Externí odkaz:
https://doaj.org/article/33708b8689b243ebbac5d3b8b35c2f99
Autor:
Lemya Mezdour, Tarek Mansoul, Riad Boussaid, Ahcene Bariout, Lamia Hassani, Amel Gherfi, Asma Bouhila, Ahmed Samaouel Chehad
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A165-A166
Autor:
Lemya Mezdour, Tarek Mansoul, Riad Boussaid, Ahcene Bariout, Lamia Hassani, Amel Gherfi, Asma Bouhila, Ahmed Samaouel Chehad
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A334
Autor:
P. Tilleul, Martine Babiard, Najet Yagoubi, Philippe-Henri Secrétan, Hassane Sadou Yayé, A. Bellanger, Haroun Aouati, Ivo B. Rietveld, Bernard Do, Lamia Hassani
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2019, 178, pp.112896. ⟨10.1016/j.jpba.2019.112896⟩
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2019, 178, pp.112896. ⟨10.1016/j.jpba.2019.112896⟩
The generic Mylan® etoposide (ETP) has been investigated as an alternative for Etopophos®, in part due to a global shortage of the latter. The generic alternative is different both in its formulation and in its very limited stability (6 h at 25 °C
Autor:
Caroline Hochart, Lamia Hassani, A. Bellanger, S. Taillibert, Khe Hoang Xuan, Yasmine Hassani
Publikováno v:
Bulletin du Cancer. 99:513-520
In 2007, the use of a new therapeutic association that included two expensive drugs (bevacizumab and irinotecan), used in second line treatment for progressive glioblastoma, led to the increase of the monitoring and self-evaluation of the medical pre
Autor:
Yasmine, Hassani, Caroline, Hochart, Lamia, Hassani, Sophie, Taillibert, Khe Hoang, Xuan, Agnès, Bellanger
Publikováno v:
Bulletin du cancer. 99(5)
In 2007, the use of a new therapeutic association that included two expensive drugs (bevacizumab and irinotecan), used in second line treatment for progressive glioblastoma, led to the increase of the monitoring and self-evaluation of the medical pre
Autor:
Houssen, Moïse1 (AUTHOR) azadmoise@gmail.com, Secretan, Philippe-Henri2 (AUTHOR) philippe-henri.secretan@universite-paris-saclay.fr, Nobilet, Loup1 (AUTHOR) loup.nobilet@aphp.fr, Jossot, Kilian1 (AUTHOR) laura.guichard@aphp.fr, Guichard, Laura1 (AUTHOR) cedric.mwamba@aphp.fr, Mwamba, Cédric1 (AUTHOR) davidngy97@gmail.com, Ngy, David1 (AUTHOR) lamia.hassani@aphp.fr, Hassani, Lamia1 (AUTHOR) marie.antignac@aphp.fr, Solgadi, Audrey3 (AUTHOR) audrey.solgadi@universite-paris-saclay.fr, Antignac, Marie1,4 (AUTHOR) helga.junot@aphp.fr, Do, Bernard5,6 (AUTHOR) bernard.do@universite-paris-saclay.fr, Junot, Helga1 (AUTHOR), Sadou Yayé, Hassane1 (AUTHOR) philippe-henri.secretan@universite-paris-saclay.fr
Publikováno v:
Pharmaceutics. Aug2024, Vol. 16 Issue 8, p977. 14p.
Autor:
Roussel-Simonin, Cyril1, Gougis, Paul1,2, Lassoued, Donia1, Vozy, Aurore1,3, Veyri, Marianne1,4, Morardet, Laetitia1, Wassermann, Johanna1, Foka Tichoue, Hervé1, Jaffrelot, Loïc1, Hassani, Lamia5, Perrier, Alexandre6, Bergeret, Sebastien7, Taillade, Laurent1, Spano, Jean-Philippe1,4, Campedel, Luca1, Abbar, Baptiste1,3
Publikováno v:
Acta Oncologica. Jun2023, Vol. 62 Issue 6, p579-586. 8p. 1 Diagram, 3 Charts, 2 Graphs.